The research, which provides proof-of-principle for the feasibility of combining induced pluripotent stem cell technology and genetic correction to treat muscular dystrophy, could present a major step forward in autologous cell-based therapies for DMD and similar conditions and should pave the way for testing the approach in reprogrammed human ... (more)
http://www.sciencedaily.com/releases/2013/03/130305131158.htm
http://www.sciencedaily.com/releases/2013/03/130305131158.htm
No comments:
Post a Comment